Why BGPT?
logo

Assess an author's data and outputs

See the raw experimental evidence behind an author's publications and reproducibility signals.







Press Enter ↡ to solve



    Fuel Your Discoveries




     Quick Explanation



    Qing Li (as provided) is insufficiently evidenced for a rigorous bio-scientific author review: the prompt contains author-card metadata that is internally ambiguous and does not provide attributable, DOI-verifiable publications that match β€œQing Li” to the listed raw research items.
    Because an evidence-based review must not conflate identities, I’m limiting conclusions to what is explicitly provided in your input and to broadly supported publication-metric principles (e.g., h-index meaning/limitations).



     Long Explanation



    Author Review: Qing Li β€” evidence-based scientific strength critique

    Date context: 2026-04-16 (user-specified). Focus: only biology/bioinformatics. Skeptical, falsification-oriented, and citation-grounded.

    1) Identity/attribution problem (major blocker)

    The input provides two incompatible author β€œprofiles”: one section claims β€œQ. Li” has h-index of 0, citations 0, and 2 papers (with titles that look non-bioinformatics), while another section provides OpenAlex-like β€œmatches” where a different β€œQing Li” record has high works/citations and an unrelated topic distribution. Without DOI-verifiable publication attribution to a single β€œQing Li,” any claim that ties the listed raw research items to β€œQing Li” would be a category error.
    What I can do safely: (i) critique scientific strength mechanisms (rigor, reproducibility, confounds) and (ii) quantify evidence-strength patterns from the raw paper excerpts you providedβ€”but only as β€œpaper-level evidence quality,” not β€œauthor-level capability,” unless attribution is proven.

    2) Evidence-quality snapshot (from your provided paper-level raw excerpts)

    Your raw excerpts include multiple DOI-bearing papers across immunology, neuroscience, plant biology, computational methods, microbiome, and materials/thermoelectricity. I’ll visualize: (a) reproducibility score distribution (where present), (b) typical sample-size scale, and (c) whether data/code availability is explicit.
    Important skepticism: these are paper-level metadata you supplied. They do not demonstrate that the same author β€œQing Li” produced them.
    Interpretation (skeptical):
    • Where reproducibility is β€œlow-ish,” it often corresponds to narrative reviews with no underlying dataset, or preprint-/request-only data. Example: narrative review reproducibility score 4 (your excerpt) for viral oncogenesis.
    • Where reproducibility is β€œhigh,” it frequently aligns with public embeddings/code/data in computational work, e.g., PINNACLE (your excerpt: code/data availability via figshare/GitHub/project site).
    Skeptical interpretation: Sample size can be enormous (cells) for computational workflows (e.g., PINNACLE uses Tabula Sapiens cell atlas) but can be very small in wet-lab animal studies (e.g., LPFC experiment uses 2 macaques) . Small subject counts can still be informative, but they can inflate uncertainty and sensitivity to cohort-specific effects.

    3) What this implies for β€œQing Li” author-level strength

    • Cannot responsibly assign these paper-level evidence properties to β€œQing Li” without unambiguous author-to-DOI linkage.
    • Given the mismatch in your supplied author metrics/affiliation/paper list, the highest-probability failure mode is identity conflationβ€”a known and severe scientific error that corrupts review conclusions.
    • Therefore, my author-level scoring below reflects the limitations of the provided evidence, not a biological indictment of Qing Li’s actual scientific output.
    Why this matters: reproducibility depends heavily on whether raw data, code, and processed values can be verified independently.
    As a general metric-interpretation caution: the h-index is a bibliometric summary and can be misleading when study counts, time since publication, field norms, and identity conflation vary.

    4) Blind spots / likely errors to watch

    • Identity conflation is the dominant risk here (multiple β€œQing Li” records with different citation profiles).
    • Cross-field relevance mismatch: some provided author-paper titles appear unrelated to biology/bioinformatics (based on title alone), so domain-fit could be wrong if identity is wrong.
    • Correlation β‰  causation: several excerpted papers are reviews or hypothesis-generating, and even experimental work can be correlational at the mechanistic level (your excerpts themselves flag limitations like narrative selection bias or small N).
    • Reproducibility asymmetry: wet-lab systems can be reproducible within a lab but harder to replicate across labs without datasets/code; computational papers often improve reproducibility via open artifacts.

    5) What would change my conclusion (disproof targets)

    • If you provide an unambiguous DOI list of β€œQing Li”’s publications (or ORCID), I can recompute: publication-level rigor/reproducibility and then assign author-level scores with evidence.
    • If identity conflation is ruled out (same ORCID/affiliation + consistent DOI authorship), then I’d re-evaluate whether the paper-level evidence quality corresponds to the author’s true output.
    Next action button (recommended): run a full attribution-and-evidence check by resolving which β€œQing Li” corresponds to which DOIs, then reassess rigor/reproducibility per publication.


    Feedback:   

    Updated: April 16, 2026

    BGPT Author Review



    Scientific Quality

    20%

    The provided input does not supply DOI-verifiable, unambiguous attribution of publications to β€œQing Li,” so I cannot assess scientific merit by actual biological/bioinformatics output. The available author-metric snippets appear internally conflicting (identity conflation risk), which dominates the uncertainty. Paper-level rigor cues from the raw excerpts cannot be safely mapped to the author without clearer identity/ORCID/DOI list.



    Communication Quality

    40%

    The input does not include Qing Li’s authored abstracts, methods, figures, or writing samplesβ€”only meta-metadata. Therefore communication quality cannot be evaluated; the only available critique targets the presentation completeness of the provided profile (insufficient).



    Author Novelty

    30%

    No unambiguous set of Qing Li’s publications in the biological domain is provided with attribution. Novelty cannot be assessed reliably; the paper list/title fragments appear inconsistent with the detailed raw research excerpts.



    Scientific Rigor

    20%

    Rigor assessment requires reading the actual methods/results for Qing Li’s works or at least having an unambiguous DOI set. The prompt’s identity conflict prevents rigorous author-level evaluation; at best, reproducibility considerations from unrelated excerpted papers are not assignable to the author.

     Top Data Sources ExportMCP



     Analysis Wizard



    I will ingest the provided DOI set, deduplicate by ORCID/author order, extract reproducibility/data-availability fields, then generate author-level evidence tables and plots that flag identity conflation.



     Hypothesis Graveyard



    The simplest narrativeβ€”that the provided raw excerpts all reflect Qing Li’s workβ€”is unlikely unless DOI authorship and ORCID attribution are proven; otherwise it collapses under identity-conflation disproof.

     Science Art


    Author Review: Qing Li Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT